Literature DB >> 24625504

Limited effectiveness for the therapeutic blockade of interferon α in systemic lupus erythematosus: a possible role for type III interferons.

Luis M Amezcua-Guerra1, Diana Ferrusquía-Toriz2, Diana Castillo-Martínez2, Ricardo Márquez-Velasco2, Adriana Karina Chávez-Rueda2, Rafael Bojalil3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24625504     DOI： 10.1093/rheumatology/keu020

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.

Authors:  W E O'Gorman; D S Kong; I M Balboni; P Rudra; C R Bolen; D Ghosh; M M Davis; G P Nolan; E W Y Hsieh
Journal:  J Autoimmun       Date:  2017-04-04       Impact factor: 7.094

2.  A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus.

Authors:  Shereen Oon; Huy Huynh; Tsin Yee Tai; Milica Ng; Katherine Monaghan; Mark Biondo; Gino Vairo; Eugene Maraskovsky; Andrew D Nash; Ian P Wicks; Nicholas J Wilson
Journal:  JCI Insight       Date:  2016-05-05

3.  Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.

Authors:  Rishi R Goel; Xinghao Wang; Liam J O'Neil; Shuichiro Nakabo; Kowser Hasneen; Sarthak Gupta; Gustaf Wigerblad; Luz P Blanco; Jeffrey B Kopp; Maria I Morasso; Sergei V Kotenko; Zu-Xi Yu; Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

Review 4.  Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway.

Authors:  Shereen Oon; Nicholas J Wilson; Ian Wicks
Journal:  Clin Transl Immunology       Date:  2016-05-13

5.  A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding.

Authors:  Bruno Hernáez; Juan Manuel Alonso-Lobo; Imma Montanuy; Cornelius Fischer; Sascha Sauer; Luis Sigal; Noemí Sevilla; Antonio Alcamí
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

Review 6.  IFN-γ, should not be ignored in SLE.

Authors:  Wenping Liu; Shumin Zhang; Jibo Wang
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

7.  Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Authors:  Agneta Zickert; Vilija Oke; Ioannis Parodis; Elisabet Svenungsson; Yvonne Sundström; Iva Gunnarsson
Journal:  Lupus Sci Med       Date:  2016-11-22

8.  Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis.

Authors:  Leixi Xue; Lei Liu; Jun Huang; Jian Wen; Ru Yang; Lin Bo; Mei Tang; Yi Zhang; Zhichun Liu
Journal:  Biomed Res Int       Date:  2017-11-26       Impact factor: 3.411

Review 9.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

10.  A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus.

Authors:  Shereen Oon; Katherine Monaghan; Milica Ng; Alberta Hoi; Eric Morand; Gino Vairo; Eugene Maraskovsky; Andrew D Nash; Ian P Wicks; Nicholas J Wilson
Journal:  Clin Transl Immunology       Date:  2019-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.